Not logged in Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC Tsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Bonanno, Laura; Domine, Manuel; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long Share Save
Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis Wang, Jie; Wu, Yi-Long; Lu, Shun; Wang, Qun; Li, Shanqing; Zhong, Wen-Zhao; Wang, Qiming; Li, Wei; Wang, Buhai; Chen, Jun; Cheng, Ying; Duan, Hongbing; Li, Gaofeng; Shan, Li; Liu, Yangbo; Liu, Jing; Huang, Xiangning; Bolanos, Ana; He, Jie Share Save
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC Tsuboi, Masahiro; Herbst, Roy S.; John, Thomas; Kato, Terufumi; Majem, Margarita; Grohe, Christian; Wang, Jie; Goldman, Jonathan W.; Lu, Shun; Su, Wu-Chou; de Marinis, Filippo; Shepherd, Frances A.; Lee, Ki Hyeong; Le, Nhieu Thi; Dechaphunkul, Arunee; Kowalski, Dariusz; Poole, Lynne; Bolanos, Ana; Rukazenkov, Yuri; Wu, Yi-Long Share Save
Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA Tsuboi, M.; Wu, Y-L.; Grohe, C.; John, T.; Majem Tarruella, M.; Wang, J.; Kato, T.; Goldman, J. W.; Kim, S-W.; Yu, C-J.; Vu, H. Vinh; Mukhametshina, G.; Akewanlop, C.; de Marinis, F.; Shepherd, F. A.; Urban, D.; Stachowiak, M.; Bolanos, A. L.; Huang, X.; Herbst, R. S. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
